OBR Daily Commentary

forumImage

Merck, Samsung Accelerate a Biosimilar Price War

(Bloomberg) July 24, 2017 - Back in November, Pfizer Inc. launched its biosimilar of Johnson & Johnson's Remicade at just a 15 percent discount to the original's list price. That disappointed anyone hoping biosimilars would bring a golden age of cheaper drugs. But then Merck & Co. and Samsung Bioepis had to ruin the party on Monday, by launching a competing biosimilar at a 35 percent discount to Remicade's list price.

Read Article arrow

Winston Wong, PharmD (Posted: August 04, 2017)

quotesThe initial release discount of 15% by Pfizer did not spark much uptake, mainly because, in my opinion, a 15% by J&J was well within striking range. Now with a 35% discount on the table, the sandbox should become more stirred up. Not that 35% is not within J&J's range as well, but the payers need to step up to the plate and drive utilization.quotes

Reply

Add Comment 1 Comment(s)

Meet the Editorial Board

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Associate Cancer Center Director, Yale Cancer Center P...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...